Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. AUTOMOBILITY Scripps Howard columnist Jay Ambrose cites Sam Kazman’s work on the deadly effects…
Op-Eds
Fuel Efficiency Trade-Offs
Monday's Page One article “Drumbeat grows louder for fuel efficiency” cites John Lichtblau's claim that Congress missed an opportunity in the recently enacted energy…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. HEALTH & SAFETY Tempers run high in California at a public meeting over whether to…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. AUTOMOBILITY Forbes reports on the National Highway Traffic Safety Administration’s plan to update its fuel economy…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. E-COMMERCE Real estate company Remax announces the creation of an online database of homes for sale…
Op-Eds
Tobacco Deal-Breaker?
“No State shall, without the Consent of Congress, . . . enter into any Agreement or Compact with another State.” —- U.S. Constitution, Article I,…